The Egyptian Drug Authority announces the publication of the second edition of the Regulatory Guide on the Mechanism for Adding/Transferring the Manufacturing Site of Locally Registered Human and Veterinary Medicinal Products for the Year 2025.

This comes in light of the Egyptian Drug Authority’s support for investment and the expansion of local manufacturing, and in order to ensure the availability of medicinal products with high safety, quality, and efficacy — which will benefit the health of Egyptian citizens.

To view the second edition of the Regulatory Guide on the Mechanism for Adding/Transferring the Manufacturing Site of Locally Registered Human and Veterinary Medicinal Products for the Year 2025, please click on the link: